Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's disease
| Image |  |
|---|---|
| Description | scientific article published on 10 August 2018 |
| Author/s | |
| Publication date | August 10, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |